Mabwell (Shanghai) Bioscience Co., Ltd. Class H (2493) Stock Statistics & Valuation Metrics

Mabwell (Shanghai) Bioscience Co., Ltd. Class H has a market cap or net worth of HKD 13.86B. The enterprise value is HKD 11.43B.

Market Cap

HKD 13.86B

Enterprise Value

HKD 11.43B

Mabwell (Shanghai) Bioscience Co., Ltd. Class H has 47,130,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

47,130,200

Owned by Insiders

―

Owned by Institutions

―

Mabwell (Shanghai) Bioscience Co., Ltd. Class H’s return on equity (ROE) is -2.77 and return on invested capital (ROIC) is -27.74%.

Return on Equity (ROE)

-2.77

Return on Assets (ROA)

-0.21

Return on Invested Capital (ROIC)

-27.74%

Return on Capital Employed (ROCE)

-0.42

Revenue Per Employee

500.01K

Profits Per Employee

-731.57K

Employee Count

1,325

Asset Turnover

0.15

Inventory Turnover

0.34

The current PE Ratio of Mabwell (Shanghai) Bioscience Co., Ltd. Class H is -6.54. Mabwell (Shanghai) Bioscience Co., Ltd. Class H’s PEG ratio is -0.38.

PE Ratio

-6.54

PS Ratio

9.81

PB Ratio

7.01

Price to FCF

-9.55

Price to Operating Cash Flow

-8.01

PEG Ratio

-0.38

In the last 12 months, Mabwell (Shanghai) Bioscience Co., Ltd. Class H had revenue of 662.52M and earned -969.33M in profits. Earnings per share was -2.43.

Revenue

662.52M

Gross Profit

598.05M

Operating Income

-955.32M

Pretax Income

-956.39M

Net Income

-969.33M

EBITDA

-647.88M

Earnings Per Share (EPS)

-2.43

In the last 12 months, operating cash flow was -764.00M and capital expenditures -133.66M, giving a free cash flow of -897.77M billion.

Operating Cash Flow

-764.00M

Free Cash Flow

-897.77M

Free Cash Flow per Share

-2.26

Mabwell (Shanghai) Bioscience Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-10.47%

Earnings Yield

-15.35%

Beta

-0.00

52-Week Price Change

-34.42%

50-Day Moving Average

20.33

200-Day Moving Average

22.53

Relative Strength Index (RSI)

28.94

Average Volume (3m)

246.75K

Mabwell (Shanghai) Bioscience Co., Ltd. Class H upcoming earnings date is Apr 07, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 28, 2026

Next Earnings Date

Apr 07, 2027

Ex-Dividend Date

―

Mabwell (Shanghai) Bioscience Co., Ltd. Class H as a current ratio of 0.90, with Debt / Equity ratio of 744.39%

Current Ratio

0.90

Quick Ratio

0.82

Debt to Market Cap

0.26

Net Debt to EBITDA

-1.66

Interest Coverage Ratio

-10.52

In the past 12 months, Mabwell (Shanghai) Bioscience Co., Ltd. Class H has paid 15.86M in taxes.

Income Tax

15.86M

Effective Tax Rate

-0.02

Mabwell (Shanghai) Bioscience Co., Ltd. Class H EV to EBITDA ratio is -15.09, with an EV/FCF ratio of -10.80.

EV to Sales

11.10

EV to EBITDA

-15.09

EV to Free Cash Flow

-10.80

EV to Operating Cash Flow

-12.69

Mabwell (Shanghai) Bioscience Co., Ltd. Class H has HKD 2.29B in cash and marketable securities with HKD 3.35B in debt, giving a net cash position of -HKD 1.06B billion.

Cash & Marketable Securities

HKD 2.29B

Total Debt

HKD 3.35B

Net Cash

-HKD 1.06B

Net Cash Per Share

-HKD 22.51

Tangible Book Value Per Share

HKD 2.06

Gross margin is 74.55%, with operating margin of -98.36%, and net profit margin of -107.54%.

Gross Margin

74.55%

Operating Margin

-98.36%

Pretax Margin

-106.21%

Net Profit Margin

-107.54%

EBITDA Margin

-73.52%

EBIT Margin

-92.28%

The average price target for Mabwell (Shanghai) Bioscience Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

385.38%

EPS Growth Forecast

―

Smart Score

1

AI Score

44